Effect of Alzheimer disease genetic risk disclosure on dietary supplement use(1)(2)(3)(4)

Background: Genetic susceptibility testing for Alzheimer disease (AD) with APOE genotype disclosure is not recommended for clinical use but is available through direct-to-consumer (DTC) genetic testing companies. Little is known about whether APOE genotype disclosure would actually prompt changes in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vernarelli, Jacqueline A, Roberts, J Scott, Hiraki, Susan, Chen, Clara A, Cupples, L Adrienne, Green, Robert C
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Nutrition 2010
Assuntos:
Dietary supplements
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854909/
https://ncbi.nlm.nih.gov/pubmed/20219963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3945/ajcn.2009.28981
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados